Compare · RVTY vs SEER
RVTY vs SEER
Side-by-side comparison of Revvity Inc. (RVTY) and Seer Inc. (SEER): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RVTY and SEER operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
- RVTY is the larger of the two at $14.10B, about 126.1x SEER ($111.9M).
- Over the past year, RVTY is up 38.4% and SEER is down 2.6% - RVTY leads by 41.0 points.
- SEER has been more active in the news (7 items in the past 4 weeks vs 6 for RVTY).
- RVTY has more recent analyst coverage (20 ratings vs 8 for SEER).
- Company
- Revvity Inc.
- Seer Inc.
- Price
- $126.32+1.23%
- $2.02-1.22%
- Market cap
- $14.10B
- $111.9M
- 1M return
- +13.28%
- -6.25%
- 1Y return
- +38.36%
- -2.64%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 6
- 7
- Recent ratings
- 20
- 8
Seer Inc.
Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Latest RVTY
- Director Michas Alexis P gifted 285 shares (SEC Form 4)
- Officer Goldberg Joel S gifted 27,785 shares and received a gift of 27,785 shares, decreasing direct ownership by 67% to 13,729 units (SEC Form 4)
- Officer Singh Prahlad R. gifted 67,286 shares and received a gift of 67,286 shares, decreasing direct ownership by 59% to 46,026 units (SEC Form 4)
- SEC Form 10-Q filed by Revvity Inc.
- Revvity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Revvity Announces Financial Results for the Second Quarter of 2026
- Revvity Board Declares Quarterly Dividend
- Vice President and CAO Gonzales Anita sold $9,306 worth of shares (85 units at $109.48) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 7,201 units (SEC Form 4)
- Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
- Revvity to Hold Earnings Call on Tuesday, August 4, 2026
Latest SEER
- PRESIDENT & CFO Horn David R. sold $14,809 worth of shares (7,309 units at $2.03), decreasing direct ownership by 1% to 486,650 units (SEC Form 4) to cover taxes
- Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
- SEC Form 10-Q filed by Seer Inc.
- Seer Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
- Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference
- Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
- Seer Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Seer Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.